Seeking Alpha

Sequenom (SQNM) rises 4% after announcing "numerous leading healthcare providers" in the U.S....

Sequenom (SQNM) rises 4% after announcing "numerous leading healthcare providers" in the U.S. have begun ordering its MaterniT21 product, which is used to analyze a baby's DNA during pregnancy for signs of Down Syndrome. Ed Pullen believes the nature of Sequenom's product "raises huge questions" about its usage. (previously)
Comments (1)
  • Director one
    , contributor
    Comments (59) | Send Message
     
    This should reduce medical costs in the long run for many families.....Who is Ed Pullen a short in the stock?
    19 Dec 2011, 08:48 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|